|
|
Stem Cell Related Patent Number US5635388
Title: | Agonist antibodies against the flk2/flt3 receptor and uses thereof | Inventors: | Bennett, Brian D.; Pacifica, CA, USA
Broz, SUSA n D.; San Bruno, CA, USA Matthews, William; Woodside, CA, USA
Zeigler, Francis C.; San Mateo, CA, USA | Summary: | This invention describes agonist antibodies which bind to the extracellular domain of the flk2/flt3 receptor and thereby activate the intracellular kinase domain. The labeled antibodies are useful as diagnostics for detecting the presence of the flk2/flt3 receptor in primitive hematopoietic cells, and the antibodies are able to cause primitive hematopoietic cells to proliferate and/or to differentiate and thereby enhance repopulation of mature blood cell lineages in a mammal which has undergone chemo- or radiation therapy or bone marrow transplantation. The antibodies are further useful for treating mammals which have suffered a decrease in blood cells as a consequence of disease or a hemorrhage, among other disorders. | Abstract: | Agonist antibodies are disclosed which bind to the extracellular domain of the flk2/flt3 receptor and thereby activate the intracellular kinase domain thereof. The labeled antibodies are useful as diagnostics for detecting the presence of the flk2/flt3 receptor in primitive hematopoietic cells for example. The antibodies are able to cause primitive hematopoietic cells to proliferate and/or differentiate and thereby enhance repopulation of mature blood cell lineages in a mammal which has undergone chemo- or radiation therapy or bone marrow transplantation. The antibodies are further useful for treating mammals which have suffered a decrease in blood cells as a consequence of disease or a hemorrhage, for example. | US Patent Website: | Click Here for Full Text of Patent | Title Number: | US5635388 | Application Number: | US1994000222299 | Date Filed: | 04/04/1994 | Date Published: | 03/06/1997 | Assignee: | Genentech, Inc., South San Francisco, CA, USA |
|
|